Riverain Technologies Gets FDA OK for New Image Enhancement Software

ClearRead +Confirm, new software from Riverain Technologies that improves the clarity of conventional X-ray images, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). According to the press release, portable chest X-ray machines are routinely used to confirm the placement of lines and tubes but they often need adjustments to make the edges and tips of the devices stand out, which can be time consuming. ClearRead +Confirm increases readability by selectively increasing contrast and suppressing the clavicles and ribs in the image, removing obstacles that could obscure the visibility of feeding, drug delivery and pain management tubes, lines and cardiac wires. In a Georgetown University reader study, 334 chest X-rays were each reviewed by 10 radiologists with and without ClearRead +Confirm. The software reduced reading times by approximately 19% without compromising accuracy.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.